Product Information

LISINOPRIL 30 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0541 per EA under NDC 31722017905. Its NADAC has been published 150 times since Oct 11, 2023.

FDA first approved this application on Jul 1, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISINOPRIL 30 MG TABLET

Lisinopril
$0.0541per EA

Strength

30 mg/1

NDC

31722017905

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LISINOPRIL

Approval Type

Generic (ANDA)

FDA Application

ANDA075903

FDA Approved

7/1/2002

TE Code

AB

On Market Since

8/17/2021

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for LISINOPRIL 30 MG TABLET has been published 150 times since Oct 11, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0541 per EA
All-time high$0.0584 (Dec 13, 2023)
All-time low$0.0419 (Nov 20, 2024)
52-week high$0.0556
52-week low$0.0540
Median price$0.0544
Average price$0.0534
Largest weekly change-25.1% (Nov 20, 2024)
Weeks tracked150
Tracking sinceOct 11, 2023

Price History

1W

-0.1%

1M

-0.1%

3M

-2.5%

6M

-0.5%

1Y

-1.4%

3Y

N/A

5Y

N/A

All

+1.7%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISINOPRIL 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL 30 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0541 per EA (NDC 31722017905), effective Aug 19, 2026.

How has the price of LISINOPRIL 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for LISINOPRIL 30 MG TABLET has held within roughly two percent of its current level. It has been tracked across 150 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for LISINOPRIL 30 MG TABLET?

Since Oct 11, 2023, the NADAC for LISINOPRIL 30 MG TABLET has ranged from a low of $0.0419 (Nov 20, 2024) to a high of $0.0584 (Dec 13, 2023), with a median of $0.0544 per EA.

Are there cheaper alternatives to LISINOPRIL 30 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LISINOPRIL 30 MG TABLET, is $0.0541 per EA — about 0% below LISINOPRIL 30 MG TABLET.

Who manufactures LISINOPRIL 30 MG TABLET?

LISINOPRIL 30 MG TABLET (NDC 31722017905) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.